Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Cardiogenetics. 2022 Jan 6;12(1):24–36. doi: 10.3390/cardiogenetics12010003

Table 1.

Demographics and clinical characteristics of 19 probands and relatives with pathogenic or likely pathogenic variants in the desmoplakin gene (DSP).

Characteristic Relatives Probands p-Value
N = 8 N = 11
Age at Diagnosis (years), median (IQR) 35.5 (31.0–48.0) 42.0 (30.0–48.0) 0.53
Sex (%) 1.00
 Female 5 (62%) 7 (64%)
 Male 3 (38%) 4 (36%)
Race/Ethnicity (%) 1.00
 Hispanic Latinx/White 1 (12%) 1 (9%)
 White 7 (88%) 9 (82%)
 Unknown 0 (0%) 1 (9%)
Symptoms at Initial Assessment (%)
 NYHA Class 0.11
  I 5 (62%) 6 (55%)
  II 1 (12%) 5 (45%)
  III 2 (25%) 0 (0%)
 Dyspnea 2 (25%) 1 (9%) 0.55
 Chest Pain 2 (25%) 1 (9%) 0.55
 Palpitations 5 (62%) 3 (27%) 0.18
 Presyncope 1 (12%) 2 (18%) 1.00
 Syncope 1 (12%) 0 (0%) 0.42
 Edema 0 (0%) 0 (0%) 1.00
Family History of SCD (%) 5 (45%)
Family History of DCM (%) 5 (45%)

Abbreviations: NYHA = New York Heart Association; SCD = sudden cardiac death; DCM = dilated cardiomyopathy.